Matt Davis Therapeutic Goods Administration

Matt Davis holds the position of Director, Inspections Section with the Manufacturing Quality Branch, Therapeutic Goods Administration. Matt leads a team of 30 inspectors located across Australia and is responsible for the management and delivery of the GMP inspection program for domestic and overseas manufacturers of medicines, bloods, tissues, cell and gene therapies.